MYD88 and Alzheimer disease: These results suggest that MyD88 pathway has a significant impact on blood monocyte populations in this mouse model of AD, which exhibits increased amount of the resident subset and a decreased level of inflammatory monocytes in a context of partial MyD88 deficiency.